EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery and Characterisation of Novel Poly-Histidine-Poly-Glycine Peptides as Matrix Metalloproteinase Inhibitors

He Wang, Wenchao Cai, Zhiyu Tang, Juanli Fu, Enrico König iD, Nanwen Zhang iD, Xiaole Chen iD, Tianbao Chen iD, Chris Shaw

Biomolecules · 2025

DOI: 10.3390/biom15050706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von He Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350000, China. Hauptthemen laut MEDLINE: Matrix Metalloproteinase Inhibitors, Peptides, Histidine, Matrix Metalloproteinase 1. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For the first time, two poly-histidine-poly-glycine peptides (pHpG-H5 and pHpG-H7) were identified as promising candidates for matrix metalloproteinase inhibitors. cDNAs encoding pHpG-H5 and pHpG-H7 peptides were isolated from the Atheris squamigera cDNA library constructed using oligo(dT)-primed reverse transcription. Deduced sequences of pHpG peptides were systematically organised and utilised as templates for synthesising chemical replicates. All synthetic pHpG peptides exhibited inhibitory effects on human matrix metalloproteinase-1 (MMP-1). Spectroscopic analyses and molecular modelling demonstrated that pHpG peptides disrupt zinc ion coordination within the central catalytic domain of MMP-1, thereby inhibiting its enzymatic activity. As a novel peptide inhibitor of matrix metalloproteinase, pHpG-H7 modulates multiple biological processes, such as cell migration and angiogenesis, suggesting significant therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase InhibitorsPeptidesHistidineMatrix Metalloproteinase 1HumansCell MovementAmino Acid Sequence

Stichwörter der Autor:innen

matrix metalloproteinasesmolecular cloningpeptide inhibitorsnake venom

Substanzen

Matrix Metalloproteinase InhibitorsPeptidesHistidineMatrix Metalloproteinase 1polyglycinepolyhistidine

Autor:innen und Institutionen

  • School of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350000, China.
  • Department of Bioengineering and Biopharmaceutics, School of Pharmacy, Fujian Medical University, Fuzhou 350000, China.
  • Laboratory of Synthetic and Structural Vaccinology, University of Trento, 38100 Trento, Italy.
  • Medicine Natural Peptide Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast BT7 1NN, UK.

ORCID-Profile: Enrico König, Nanwen Zhang, Xiaole Chen, Tianbao Chen

Förderung

  • Natural Science Foundation of Fujian Province, China

Zitieren

APA

Wang, H., Cai, W., Tang, Z., Fu, J., König, E., Zhang, N., Chen, X., Chen, T., & Shaw, C. (2025). Discovery and Characterisation of Novel Poly-Histidine-Poly-Glycine Peptides as Matrix Metalloproteinase Inhibitors. Biomolecules. https://doi.org/10.3390/biom15050706

Vancouver

Wang H, Cai W, Tang Z, Fu J, König E, Zhang N, et al. Discovery and Characterisation of Novel Poly-Histidine-Poly-Glycine Peptides as Matrix Metalloproteinase Inhibitors. Biomolecules. 2025. doi:10.3390/biom15050706

BibTeX
@article{Wang2025,
  author = {Wang, He and Cai, Wenchao and Tang, Zhiyu and Fu, Juanli and König, Enrico and Zhang, Nanwen and Chen, Xiaole and Chen, Tianbao and Shaw, Chris},
  title = {Discovery and Characterisation of Novel Poly-Histidine-Poly-Glycine Peptides as Matrix Metalloproteinase Inhibitors},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15050706}
}
Kostenlos starten →